Finance News – Zenas Biopharma
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Cryptocurrency
Crypto Assets
Investors
Stocks
Ethereum
Stock Market
Shares
Stock
Markets
Blockchain
Xrp
Price
Eth
Investment
Sec
Stablecoin
Etf
Trade
Earnings
Revenue
Coinbase
Solana
China
Usd
Index
Bse
Token
Nasdaq
Trade War
Ipo
Wall Street
Economy
Digital Assets
Profit
Inflation
Gold
Nvidia
Interest Rates
Sp 500
Trade Deal
Binance
Sensex
Investor
Stablecoins
Sales
Private Investment
Automation
Scottish National Party
Derivatives Offerings
Liquidation Price
Cpkc
Ppp
Border Policy
Dri
Dashboard
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Business Insider Markets • May 28, 2025
Class Action Alert: Levi & Korsinsky Reminds Zenas BioPharma, Inc. (ZBIO) Investors of June 16, 2025...
Investors in Zenas BioPharma, Inc. who experienced financial losses may have an opportunity to seek compensation if they take action before the approaching mid-June 2025 deadline.
Read Full Article →
Business Insider Markets • May 27, 2025
ROSEN, SKILLED INVESTOR COUNESL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before...
Investors in Zenas BioPharma, Inc. may have the opportunity to participate in a securities class action seeking potential compensation related to alleged financial misconduct befor...
Read Full Article →